Harish Seethapathy
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Nephrology top 5%
- Surgery
- Immunology
- Co-authors
- Meghan E. SiseKerry L. ReynoldsIan A. StrohbehnDavid E. LeafSophia ZhaoDonald F. ChuteRyan J. SullivanLeyre Zubiri
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Renal Diseases and Glomerulopathies (8 papers)Renal cell carcinoma treatment (5 papers)
- Cited by
- NephrologyOncologyTransplantation
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEJournal of the American Society of Nephrology
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Harish Seethapathy
33 papers receiving 737 citations
Peers
Comparison fields: 5 of 72
- Oncology 416
- Pulmonary and Respiratory Medicine 252
- Nephrology 172
- Surgery 106
- Immunology 77
Countries citing papers authored by Harish Seethapathy
This map shows the geographic impact of Harish Seethapathy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harish Seethapathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harish Seethapathy more than expected).
Fields of papers citing papers by Harish Seethapathy
This network shows the impact of papers produced by Harish Seethapathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harish Seethapathy. The network helps show where Harish Seethapathy may publish in the future.
Co-authorship network of co-authors of Harish Seethapathy
This figure shows the co-authorship network connecting the top 25 collaborators of Harish Seethapathy. A scholar is included among the top collaborators of Harish Seethapathy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harish Seethapathy. Harish Seethapathy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 23 | |
| 6 | 16 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 0 | |
| 12 | 80 | |
| 13 | 7 | |
| 14 | 43 | |
| 15 | 205 | |
| 16 | 4 | |
| 17 | 41 | |
| 18 | 14 | |
| 19 | 5 | |
| 20 | 22 |
About Harish Seethapathy
Harish Seethapathy is a scholar working on Nephrology, Transplantation and Oncology, having authored 40 papers that have together received 751 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Nephrology (172 citations), Oncology (416 citations) and Transplantation (33 citations). Harish Seethapathy has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Meghan E. Sise, Kerry L. Reynolds, Ian A. Strohbehn, David E. Leaf, Sophia Zhao, Donald F. Chute, Ryan J. Sullivan, Leyre Zubiri, Alexandra–Chloé Villani and Frank B. Cortazar. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.